nodes	percent_of_prediction	percent_of_DWPC	metapath
Desloratadine—HRH1—atherosclerosis	0.494	1	CbGaD
Desloratadine—CYP2C19—Rosuvastatin—atherosclerosis	0.0332	0.0835	CbGbCtD
Desloratadine—CYP2C19—Simvastatin—atherosclerosis	0.0309	0.0777	CbGbCtD
Desloratadine—CYP2C19—Lovastatin—atherosclerosis	0.0302	0.076	CbGbCtD
Desloratadine—CYP2D6—Niacin—atherosclerosis	0.0297	0.0747	CbGbCtD
Desloratadine—CYP2C9—Rosuvastatin—atherosclerosis	0.0276	0.0695	CbGbCtD
Desloratadine—ABCB1—Ezetimibe—atherosclerosis	0.0268	0.0674	CbGbCtD
Desloratadine—CYP2C9—Simvastatin—atherosclerosis	0.0257	0.0646	CbGbCtD
Desloratadine—CYP2C9—Lovastatin—atherosclerosis	0.0251	0.0632	CbGbCtD
Desloratadine—CYP2C9—Pravastatin—atherosclerosis	0.0251	0.0632	CbGbCtD
Desloratadine—ABCB1—Simvastatin—atherosclerosis	0.0249	0.0627	CbGbCtD
Desloratadine—ABCB1—Lovastatin—atherosclerosis	0.0244	0.0613	CbGbCtD
Desloratadine—ABCB1—Pravastatin—atherosclerosis	0.0244	0.0613	CbGbCtD
Desloratadine—CYP2D6—Simvastatin—atherosclerosis	0.0235	0.059	CbGbCtD
Desloratadine—CYP2D6—Lovastatin—atherosclerosis	0.023	0.0578	CbGbCtD
Desloratadine—CYP2D6—Pravastatin—atherosclerosis	0.023	0.0578	CbGbCtD
Desloratadine—Azatadine—HRH1—atherosclerosis	0.00172	0.437	CrCbGaD
Desloratadine—Loratadine—HRH1—atherosclerosis	0.00163	0.414	CrCbGaD
Desloratadine—Hepatic enzyme increased—Rosuvastatin—atherosclerosis	0.00156	0.0184	CcSEcCtD
Desloratadine—Viral infection—Ezetimibe—atherosclerosis	0.00136	0.016	CcSEcCtD
Desloratadine—Viral infection—Pravastatin—atherosclerosis	0.00117	0.0138	CcSEcCtD
Desloratadine—Rash maculo-papular—Niacin—atherosclerosis	0.000975	0.0115	CcSEcCtD
Desloratadine—Breast disorder—Rosuvastatin—atherosclerosis	0.000966	0.0114	CcSEcCtD
Desloratadine—Bronchitis—Rosuvastatin—atherosclerosis	0.000889	0.0105	CcSEcCtD
Desloratadine—Breast disorder—Ezetimibe—atherosclerosis	0.000803	0.00949	CcSEcCtD
Desloratadine—Urinary tract infection—Rosuvastatin—atherosclerosis	0.000801	0.00946	CcSEcCtD
Desloratadine—Nasopharyngitis—Ezetimibe—atherosclerosis	0.000795	0.00939	CcSEcCtD
Desloratadine—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.000779	0.0092	CcSEcCtD
Desloratadine—Affect lability—Pravastatin—atherosclerosis	0.000754	0.00891	CcSEcCtD
Desloratadine—Hepatitis—Rosuvastatin—atherosclerosis	0.00074	0.00874	CcSEcCtD
Desloratadine—Pharyngitis—Rosuvastatin—atherosclerosis	0.000734	0.00867	CcSEcCtD
Desloratadine—Mood swings—Pravastatin—atherosclerosis	0.000726	0.00857	CcSEcCtD
Desloratadine—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.000714	0.00843	CcSEcCtD
Desloratadine—Bronchitis—Simvastatin—atherosclerosis	0.000705	0.00832	CcSEcCtD
Desloratadine—Nasopharyngitis—Pravastatin—atherosclerosis	0.000685	0.00809	CcSEcCtD
Desloratadine—Infestation NOS—Ezetimibe—atherosclerosis	0.000685	0.00809	CcSEcCtD
Desloratadine—Infestation—Ezetimibe—atherosclerosis	0.000685	0.00809	CcSEcCtD
Desloratadine—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.000681	0.00804	CcSEcCtD
Desloratadine—Urinary tract infection—Lovastatin—atherosclerosis	0.000679	0.00802	CcSEcCtD
Desloratadine—Mental disorder—Rosuvastatin—atherosclerosis	0.000648	0.00765	CcSEcCtD
Desloratadine—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.000648	0.00765	CcSEcCtD
Desloratadine—Bronchitis—Niacin—atherosclerosis	0.000647	0.00764	CcSEcCtD
Desloratadine—Hepatitis—Lovastatin—atherosclerosis	0.000627	0.0074	CcSEcCtD
Desloratadine—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.000616	0.00727	CcSEcCtD
Desloratadine—Hepatitis—Ezetimibe—atherosclerosis	0.000615	0.00726	CcSEcCtD
Desloratadine—Pharyngitis—Ezetimibe—atherosclerosis	0.00061	0.00721	CcSEcCtD
Desloratadine—Connective tissue disorder—Ezetimibe—atherosclerosis	0.000604	0.00714	CcSEcCtD
Desloratadine—Angioedema—Rosuvastatin—atherosclerosis	0.000589	0.00695	CcSEcCtD
Desloratadine—Hepatitis—Simvastatin—atherosclerosis	0.000587	0.00693	CcSEcCtD
Desloratadine—Amoxapine—HRH1—atherosclerosis	0.000585	0.149	CrCbGaD
Desloratadine—Urinary tract infection—Pravastatin—atherosclerosis	0.000574	0.00678	CcSEcCtD
Desloratadine—Cough—Rosuvastatin—atherosclerosis	0.000562	0.00664	CcSEcCtD
Desloratadine—Myalgia—Rosuvastatin—atherosclerosis	0.000548	0.00647	CcSEcCtD
Desloratadine—Mental disorder—Ezetimibe—atherosclerosis	0.000539	0.00636	CcSEcCtD
Desloratadine—Hepatitis—Niacin—atherosclerosis	0.000539	0.00636	CcSEcCtD
Desloratadine—Erythema—Ezetimibe—atherosclerosis	0.000535	0.00632	CcSEcCtD
Desloratadine—Hepatitis—Pravastatin—atherosclerosis	0.00053	0.00626	CcSEcCtD
Desloratadine—Pharyngitis—Pravastatin—atherosclerosis	0.000526	0.00621	CcSEcCtD
Desloratadine—Infection—Rosuvastatin—atherosclerosis	0.000522	0.00617	CcSEcCtD
Desloratadine—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000516	0.00609	CcSEcCtD
Desloratadine—Mental disorder—Simvastatin—atherosclerosis	0.000514	0.00607	CcSEcCtD
Desloratadine—Erythema—Simvastatin—atherosclerosis	0.000511	0.00603	CcSEcCtD
Desloratadine—Angioedema—Lovastatin—atherosclerosis	0.000499	0.00589	CcSEcCtD
Desloratadine—Cardiac disorder—Pravastatin—atherosclerosis	0.000492	0.00581	CcSEcCtD
Desloratadine—Angioedema—Ezetimibe—atherosclerosis	0.000489	0.00578	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000479	0.00565	CcSEcCtD
Desloratadine—Insomnia—Rosuvastatin—atherosclerosis	0.000475	0.00561	CcSEcCtD
Desloratadine—Palpitations—Ezetimibe—atherosclerosis	0.000473	0.00559	CcSEcCtD
Desloratadine—Erythema—Niacin—atherosclerosis	0.000469	0.00554	CcSEcCtD
Desloratadine—Cough—Ezetimibe—atherosclerosis	0.000467	0.00552	CcSEcCtD
Desloratadine—Angioedema—Simvastatin—atherosclerosis	0.000467	0.00551	CcSEcCtD
Desloratadine—Myalgia—Lovastatin—atherosclerosis	0.000465	0.00549	CcSEcCtD
Desloratadine—Dyspepsia—Rosuvastatin—atherosclerosis	0.000463	0.00546	CcSEcCtD
Desloratadine—Myalgia—Ezetimibe—atherosclerosis	0.000456	0.00538	CcSEcCtD
Desloratadine—Dry mouth—Lovastatin—atherosclerosis	0.000454	0.00537	CcSEcCtD
Desloratadine—Dry mouth—Ezetimibe—atherosclerosis	0.000446	0.00526	CcSEcCtD
Desloratadine—Anaphylactic shock—Lovastatin—atherosclerosis	0.000445	0.00526	CcSEcCtD
Desloratadine—Infection—Lovastatin—atherosclerosis	0.000443	0.00523	CcSEcCtD
Desloratadine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000437	0.00516	CcSEcCtD
Desloratadine—Myalgia—Simvastatin—atherosclerosis	0.000435	0.00513	CcSEcCtD
Desloratadine—Infection—Ezetimibe—atherosclerosis	0.000434	0.00513	CcSEcCtD
Desloratadine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00043	0.00508	CcSEcCtD
Desloratadine—Nervous system disorder—Ezetimibe—atherosclerosis	0.000428	0.00506	CcSEcCtD
Desloratadine—Angioedema—Niacin—atherosclerosis	0.000428	0.00506	CcSEcCtD
Desloratadine—Anorexia—Lovastatin—atherosclerosis	0.000425	0.00501	CcSEcCtD
Desloratadine—Angioedema—Pravastatin—atherosclerosis	0.000422	0.00498	CcSEcCtD
Desloratadine—Urticaria—Rosuvastatin—atherosclerosis	0.000418	0.00493	CcSEcCtD
Desloratadine—Anaphylactic shock—Simvastatin—atherosclerosis	0.000417	0.00492	CcSEcCtD
Desloratadine—Oedema—Simvastatin—atherosclerosis	0.000417	0.00492	CcSEcCtD
Desloratadine—Abdominal pain—Rosuvastatin—atherosclerosis	0.000416	0.00491	CcSEcCtD
Desloratadine—Palpitations—Niacin—atherosclerosis	0.000414	0.00489	CcSEcCtD
Desloratadine—Infection—Simvastatin—atherosclerosis	0.000414	0.00489	CcSEcCtD
Desloratadine—Cough—Niacin—atherosclerosis	0.000409	0.00483	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000406	0.00479	CcSEcCtD
Desloratadine—Insomnia—Lovastatin—atherosclerosis	0.000403	0.00476	CcSEcCtD
Desloratadine—Cough—Pravastatin—atherosclerosis	0.000403	0.00476	CcSEcCtD
Desloratadine—Myalgia—Niacin—atherosclerosis	0.000399	0.00471	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000398	0.0047	CcSEcCtD
Desloratadine—Anorexia—Simvastatin—atherosclerosis	0.000397	0.00469	CcSEcCtD
Desloratadine—Dyspnoea—Lovastatin—atherosclerosis	0.000397	0.00469	CcSEcCtD
Desloratadine—Insomnia—Ezetimibe—atherosclerosis	0.000395	0.00467	CcSEcCtD
Desloratadine—Myalgia—Pravastatin—atherosclerosis	0.000393	0.00464	CcSEcCtD
Desloratadine—Dyspepsia—Lovastatin—atherosclerosis	0.000392	0.00463	CcSEcCtD
Desloratadine—Dry mouth—Niacin—atherosclerosis	0.00039	0.00461	CcSEcCtD
Desloratadine—Dyspnoea—Ezetimibe—atherosclerosis	0.00039	0.0046	CcSEcCtD
Desloratadine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000387	0.00457	CcSEcCtD
Desloratadine—Decreased appetite—Lovastatin—atherosclerosis	0.000387	0.00457	CcSEcCtD
Desloratadine—Dyspepsia—Ezetimibe—atherosclerosis	0.000385	0.00454	CcSEcCtD
Desloratadine—Fatigue—Lovastatin—atherosclerosis	0.000384	0.00453	CcSEcCtD
Desloratadine—Anaphylactic shock—Niacin—atherosclerosis	0.000383	0.00452	CcSEcCtD
Desloratadine—Oedema—Niacin—atherosclerosis	0.000383	0.00452	CcSEcCtD
Desloratadine—Decreased appetite—Ezetimibe—atherosclerosis	0.00038	0.00448	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00038	0.00448	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000377	0.00445	CcSEcCtD
Desloratadine—Asthenia—Rosuvastatin—atherosclerosis	0.000377	0.00445	CcSEcCtD
Desloratadine—Insomnia—Simvastatin—atherosclerosis	0.000377	0.00445	CcSEcCtD
Desloratadine—Anaphylactic shock—Pravastatin—atherosclerosis	0.000377	0.00445	CcSEcCtD
Desloratadine—Oedema—Pravastatin—atherosclerosis	0.000377	0.00445	CcSEcCtD
Desloratadine—Fatigue—Ezetimibe—atherosclerosis	0.000377	0.00445	CcSEcCtD
Desloratadine—Infection—Pravastatin—atherosclerosis	0.000374	0.00442	CcSEcCtD
Desloratadine—Tachycardia—Niacin—atherosclerosis	0.000373	0.00441	CcSEcCtD
Desloratadine—Pruritus—Rosuvastatin—atherosclerosis	0.000372	0.00439	CcSEcCtD
Desloratadine—Dyspnoea—Simvastatin—atherosclerosis	0.000371	0.00439	CcSEcCtD
Desloratadine—Dyspepsia—Simvastatin—atherosclerosis	0.000367	0.00433	CcSEcCtD
Desloratadine—Anorexia—Niacin—atherosclerosis	0.000365	0.00431	CcSEcCtD
Desloratadine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000364	0.0043	CcSEcCtD
Desloratadine—Decreased appetite—Simvastatin—atherosclerosis	0.000362	0.00428	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00036	0.00425	CcSEcCtD
Desloratadine—Diarrhoea—Rosuvastatin—atherosclerosis	0.00036	0.00425	CcSEcCtD
Desloratadine—Fatigue—Simvastatin—atherosclerosis	0.000359	0.00424	CcSEcCtD
Desloratadine—Anorexia—Pravastatin—atherosclerosis	0.000359	0.00424	CcSEcCtD
Desloratadine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000357	0.00422	CcSEcCtD
Desloratadine—Urticaria—Lovastatin—atherosclerosis	0.000354	0.00418	CcSEcCtD
Desloratadine—Abdominal pain—Lovastatin—atherosclerosis	0.000352	0.00416	CcSEcCtD
Desloratadine—Body temperature increased—Lovastatin—atherosclerosis	0.000352	0.00416	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000349	0.00412	CcSEcCtD
Desloratadine—Dizziness—Rosuvastatin—atherosclerosis	0.000348	0.0041	CcSEcCtD
Desloratadine—Urticaria—Ezetimibe—atherosclerosis	0.000347	0.0041	CcSEcCtD
Desloratadine—Insomnia—Niacin—atherosclerosis	0.000346	0.00409	CcSEcCtD
Desloratadine—Abdominal pain—Ezetimibe—atherosclerosis	0.000345	0.00408	CcSEcCtD
Desloratadine—Body temperature increased—Ezetimibe—atherosclerosis	0.000345	0.00408	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000343	0.00405	CcSEcCtD
Desloratadine—Dyspnoea—Niacin—atherosclerosis	0.000341	0.00403	CcSEcCtD
Desloratadine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000341	0.00402	CcSEcCtD
Desloratadine—Insomnia—Pravastatin—atherosclerosis	0.000341	0.00402	CcSEcCtD
Desloratadine—Somnolence—Niacin—atherosclerosis	0.00034	0.00402	CcSEcCtD
Desloratadine—Dyspepsia—Niacin—atherosclerosis	0.000337	0.00398	CcSEcCtD
Desloratadine—Dyspnoea—Pravastatin—atherosclerosis	0.000336	0.00397	CcSEcCtD
Desloratadine—Decreased appetite—Niacin—atherosclerosis	0.000333	0.00393	CcSEcCtD
Desloratadine—Dyspepsia—Pravastatin—atherosclerosis	0.000332	0.00392	CcSEcCtD
Desloratadine—Rash—Rosuvastatin—atherosclerosis	0.000331	0.00391	CcSEcCtD
Desloratadine—Dermatitis—Rosuvastatin—atherosclerosis	0.000331	0.00391	CcSEcCtD
Desloratadine—Urticaria—Simvastatin—atherosclerosis	0.000331	0.00391	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Niacin—atherosclerosis	0.00033	0.0039	CcSEcCtD
Desloratadine—Abdominal pain—Simvastatin—atherosclerosis	0.000329	0.00389	CcSEcCtD
Desloratadine—Body temperature increased—Simvastatin—atherosclerosis	0.000329	0.00389	CcSEcCtD
Desloratadine—Headache—Rosuvastatin—atherosclerosis	0.000329	0.00389	CcSEcCtD
Desloratadine—Hypersensitivity—Lovastatin—atherosclerosis	0.000328	0.00388	CcSEcCtD
Desloratadine—Decreased appetite—Pravastatin—atherosclerosis	0.000327	0.00387	CcSEcCtD
Desloratadine—Fatigue—Pravastatin—atherosclerosis	0.000325	0.00383	CcSEcCtD
Desloratadine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000322	0.0038	CcSEcCtD
Desloratadine—Asthenia—Lovastatin—atherosclerosis	0.00032	0.00377	CcSEcCtD
Desloratadine—Pruritus—Lovastatin—atherosclerosis	0.000315	0.00372	CcSEcCtD
Desloratadine—Asthenia—Ezetimibe—atherosclerosis	0.000313	0.0037	CcSEcCtD
Desloratadine—Gastrointestinal pain—Niacin—atherosclerosis	0.000313	0.00369	CcSEcCtD
Desloratadine—Nausea—Rosuvastatin—atherosclerosis	0.000312	0.00369	CcSEcCtD
Desloratadine—Pruritus—Ezetimibe—atherosclerosis	0.000309	0.00365	CcSEcCtD
Desloratadine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000308	0.00364	CcSEcCtD
Desloratadine—Hypersensitivity—Simvastatin—atherosclerosis	0.000307	0.00362	CcSEcCtD
Desloratadine—Diarrhoea—Lovastatin—atherosclerosis	0.000305	0.0036	CcSEcCtD
Desloratadine—Urticaria—Niacin—atherosclerosis	0.000304	0.00359	CcSEcCtD
Desloratadine—Abdominal pain—Niacin—atherosclerosis	0.000302	0.00357	CcSEcCtD
Desloratadine—Body temperature increased—Niacin—atherosclerosis	0.000302	0.00357	CcSEcCtD
Desloratadine—Urticaria—Pravastatin—atherosclerosis	0.000299	0.00353	CcSEcCtD
Desloratadine—Asthenia—Simvastatin—atherosclerosis	0.000299	0.00353	CcSEcCtD
Desloratadine—Diarrhoea—Ezetimibe—atherosclerosis	0.000299	0.00353	CcSEcCtD
Desloratadine—Abdominal pain—Pravastatin—atherosclerosis	0.000298	0.00352	CcSEcCtD
Desloratadine—Body temperature increased—Pravastatin—atherosclerosis	0.000298	0.00352	CcSEcCtD
Desloratadine—Pruritus—Simvastatin—atherosclerosis	0.000295	0.00348	CcSEcCtD
Desloratadine—Dizziness—Lovastatin—atherosclerosis	0.000295	0.00348	CcSEcCtD
Desloratadine—Dizziness—Ezetimibe—atherosclerosis	0.000289	0.00341	CcSEcCtD
Desloratadine—Diarrhoea—Simvastatin—atherosclerosis	0.000285	0.00337	CcSEcCtD
Desloratadine—Vomiting—Lovastatin—atherosclerosis	0.000283	0.00334	CcSEcCtD
Desloratadine—Hypersensitivity—Niacin—atherosclerosis	0.000282	0.00333	CcSEcCtD
Desloratadine—Rash—Lovastatin—atherosclerosis	0.000281	0.00332	CcSEcCtD
Desloratadine—Dermatitis—Lovastatin—atherosclerosis	0.000281	0.00331	CcSEcCtD
Desloratadine—Headache—Lovastatin—atherosclerosis	0.000279	0.0033	CcSEcCtD
Desloratadine—Vomiting—Ezetimibe—atherosclerosis	0.000278	0.00328	CcSEcCtD
Desloratadine—Hypersensitivity—Pravastatin—atherosclerosis	0.000278	0.00328	CcSEcCtD
Desloratadine—Dizziness—Simvastatin—atherosclerosis	0.000276	0.00325	CcSEcCtD
Desloratadine—Rash—Ezetimibe—atherosclerosis	0.000275	0.00325	CcSEcCtD
Desloratadine—Dermatitis—Ezetimibe—atherosclerosis	0.000275	0.00325	CcSEcCtD
Desloratadine—Asthenia—Niacin—atherosclerosis	0.000275	0.00324	CcSEcCtD
Desloratadine—Headache—Ezetimibe—atherosclerosis	0.000274	0.00323	CcSEcCtD
Desloratadine—Pruritus—Niacin—atherosclerosis	0.000271	0.0032	CcSEcCtD
Desloratadine—Asthenia—Pravastatin—atherosclerosis	0.00027	0.00319	CcSEcCtD
Desloratadine—Pruritus—Pravastatin—atherosclerosis	0.000267	0.00315	CcSEcCtD
Desloratadine—Vomiting—Simvastatin—atherosclerosis	0.000265	0.00313	CcSEcCtD
Desloratadine—Nausea—Lovastatin—atherosclerosis	0.000265	0.00312	CcSEcCtD
Desloratadine—Rash—Simvastatin—atherosclerosis	0.000263	0.0031	CcSEcCtD
Desloratadine—Dermatitis—Simvastatin—atherosclerosis	0.000262	0.0031	CcSEcCtD
Desloratadine—Diarrhoea—Niacin—atherosclerosis	0.000262	0.00309	CcSEcCtD
Desloratadine—Headache—Simvastatin—atherosclerosis	0.000261	0.00308	CcSEcCtD
Desloratadine—Nausea—Ezetimibe—atherosclerosis	0.00026	0.00306	CcSEcCtD
Desloratadine—Diarrhoea—Pravastatin—atherosclerosis	0.000258	0.00304	CcSEcCtD
Desloratadine—Dizziness—Niacin—atherosclerosis	0.000253	0.00299	CcSEcCtD
Desloratadine—Dizziness—Pravastatin—atherosclerosis	0.000249	0.00294	CcSEcCtD
Desloratadine—Nausea—Simvastatin—atherosclerosis	0.000248	0.00292	CcSEcCtD
Desloratadine—Vomiting—Niacin—atherosclerosis	0.000243	0.00287	CcSEcCtD
Desloratadine—Rash—Niacin—atherosclerosis	0.000241	0.00285	CcSEcCtD
Desloratadine—Dermatitis—Niacin—atherosclerosis	0.000241	0.00285	CcSEcCtD
Desloratadine—Headache—Niacin—atherosclerosis	0.00024	0.00283	CcSEcCtD
Desloratadine—Vomiting—Pravastatin—atherosclerosis	0.00024	0.00283	CcSEcCtD
Desloratadine—Rash—Pravastatin—atherosclerosis	0.000238	0.0028	CcSEcCtD
Desloratadine—Dermatitis—Pravastatin—atherosclerosis	0.000237	0.0028	CcSEcCtD
Desloratadine—Headache—Pravastatin—atherosclerosis	0.000236	0.00279	CcSEcCtD
Desloratadine—Nausea—Niacin—atherosclerosis	0.000227	0.00268	CcSEcCtD
Desloratadine—Nausea—Pravastatin—atherosclerosis	0.000224	0.00264	CcSEcCtD
Desloratadine—ABCB1—Metabolism—APOA5—atherosclerosis	8.45e-06	0.000419	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CYP7A1—atherosclerosis	8.42e-06	0.000418	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	8.41e-06	0.000417	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—F2—atherosclerosis	8.35e-06	0.000414	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PLA2G1B—atherosclerosis	8.33e-06	0.000414	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—LPA—atherosclerosis	8.31e-06	0.000412	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	8.24e-06	0.000409	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—LPA—atherosclerosis	8.23e-06	0.000409	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—AGT—atherosclerosis	8.21e-06	0.000407	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	8.16e-06	0.000405	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	8.15e-06	0.000404	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PLA2G1B—atherosclerosis	8.13e-06	0.000404	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—EDNRA—atherosclerosis	8.1e-06	0.000402	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CCR2—atherosclerosis	8.1e-06	0.000402	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CYBA—atherosclerosis	8.07e-06	0.0004	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	8.06e-06	0.0004	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—ALOX5—atherosclerosis	8.05e-06	0.000399	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—BGN—atherosclerosis	8.04e-06	0.000399	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	8.02e-06	0.000398	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—PIK3CG—atherosclerosis	7.99e-06	0.000397	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—BGN—atherosclerosis	7.98e-06	0.000396	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—APOA5—atherosclerosis	7.96e-06	0.000395	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	7.92e-06	0.000393	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PARP1—atherosclerosis	7.9e-06	0.000392	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—GHRL—atherosclerosis	7.9e-06	0.000392	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PLAT—atherosclerosis	7.9e-06	0.000392	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—APOA5—atherosclerosis	7.89e-06	0.000392	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—ALOX5—atherosclerosis	7.86e-06	0.00039	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CYP27A1—atherosclerosis	7.78e-06	0.000386	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	7.67e-06	0.000381	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	7.67e-06	0.00038	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	7.66e-06	0.00038	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	7.6e-06	0.000377	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—F2—atherosclerosis	7.58e-06	0.000376	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	7.56e-06	0.000375	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	7.51e-06	0.000373	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	7.47e-06	0.000371	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	7.44e-06	0.000369	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	7.44e-06	0.000369	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	7.43e-06	0.000369	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ALOX5—atherosclerosis	7.4e-06	0.000367	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ALOX15—atherosclerosis	7.38e-06	0.000366	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	7.38e-06	0.000366	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	7.38e-06	0.000366	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—APOA2—atherosclerosis	7.38e-06	0.000366	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ALOX5—atherosclerosis	7.34e-06	0.000364	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ABCG5—atherosclerosis	7.29e-06	0.000362	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	7.28e-06	0.000361	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—PIK3CG—atherosclerosis	7.26e-06	0.00036	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—NAMPT—atherosclerosis	7.22e-06	0.000358	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	7.18e-06	0.000356	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—LIPC—atherosclerosis	7.17e-06	0.000356	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—APOC3—atherosclerosis	7.13e-06	0.000354	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—LDLR—atherosclerosis	7.09e-06	0.000352	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—NAMPT—atherosclerosis	7.05e-06	0.00035	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—LPA—atherosclerosis	7.04e-06	0.000349	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—LIPC—atherosclerosis	7e-06	0.000348	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—APOC3—atherosclerosis	6.96e-06	0.000345	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—KNG1—atherosclerosis	6.93e-06	0.000344	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CETP—atherosclerosis	6.92e-06	0.000344	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—LDLR—atherosclerosis	6.92e-06	0.000343	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—AGTR1—atherosclerosis	6.89e-06	0.000342	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—BGN—atherosclerosis	6.82e-06	0.000338	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	6.78e-06	0.000337	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	6.77e-06	0.000336	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—CCL2—atherosclerosis	6.76e-06	0.000335	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CETP—atherosclerosis	6.76e-06	0.000335	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—APOA5—atherosclerosis	6.75e-06	0.000335	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PLG—atherosclerosis	6.71e-06	0.000333	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—NAMPT—atherosclerosis	6.64e-06	0.00033	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	6.63e-06	0.000329	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—SCARB1—atherosclerosis	6.63e-06	0.000329	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—LIPC—atherosclerosis	6.6e-06	0.000327	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—NAMPT—atherosclerosis	6.58e-06	0.000327	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—APOC3—atherosclerosis	6.56e-06	0.000325	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	6.55e-06	0.000325	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	6.54e-06	0.000325	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—LIPC—atherosclerosis	6.54e-06	0.000325	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—LDLR—atherosclerosis	6.52e-06	0.000323	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—APOC3—atherosclerosis	6.5e-06	0.000323	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	6.49e-06	0.000322	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—SCARB1—atherosclerosis	6.47e-06	0.000321	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—LDLR—atherosclerosis	6.46e-06	0.000321	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	6.45e-06	0.00032	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	6.42e-06	0.000319	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CETP—atherosclerosis	6.37e-06	0.000316	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	6.36e-06	0.000316	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—SOCS3—atherosclerosis	6.36e-06	0.000316	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	6.35e-06	0.000315	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CETP—atherosclerosis	6.31e-06	0.000313	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ALOX5—atherosclerosis	6.27e-06	0.000311	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—HMGCR—atherosclerosis	6.26e-06	0.000311	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MMP3—atherosclerosis	6.14e-06	0.000305	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IGF2—atherosclerosis	6.11e-06	0.000303	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—HMGCR—atherosclerosis	6.11e-06	0.000303	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—SCARB1—atherosclerosis	6.1e-06	0.000303	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—SCARB1—atherosclerosis	6.04e-06	0.0003	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	5.99e-06	0.000297	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—APOB—atherosclerosis	5.94e-06	0.000295	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—CXCL8—atherosclerosis	5.89e-06	0.000292	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	5.88e-06	0.000292	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—EDN1—atherosclerosis	5.84e-06	0.00029	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CCL5—atherosclerosis	5.8e-06	0.000288	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	5.79e-06	0.000288	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—HMGCR—atherosclerosis	5.76e-06	0.000286	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—HMGCR—atherosclerosis	5.71e-06	0.000283	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—LPL—atherosclerosis	5.67e-06	0.000281	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	5.65e-06	0.00028	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—NAMPT—atherosclerosis	5.63e-06	0.000279	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	5.59e-06	0.000278	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—LIPC—atherosclerosis	5.59e-06	0.000277	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—ABCA1—atherosclerosis	5.58e-06	0.000277	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—APOC3—atherosclerosis	5.56e-06	0.000276	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—LDLR—atherosclerosis	5.52e-06	0.000274	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PRKCG—atherosclerosis	5.51e-06	0.000273	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—ABCA1—atherosclerosis	5.45e-06	0.00027	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CETP—atherosclerosis	5.39e-06	0.000268	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—SPP1—atherosclerosis	5.37e-06	0.000266	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—CXCL8—atherosclerosis	5.34e-06	0.000265	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—SCARB1—atherosclerosis	5.16e-06	0.000256	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	5.15e-06	0.000256	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ABCA1—atherosclerosis	5.13e-06	0.000255	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ABCA1—atherosclerosis	5.09e-06	0.000252	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	5.03e-06	0.00025	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PDGFB—atherosclerosis	4.97e-06	0.000246	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—HMGCR—atherosclerosis	4.88e-06	0.000242	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—AGT—atherosclerosis	4.85e-06	0.000241	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—HMOX1—atherosclerosis	4.79e-06	0.000238	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—APOE—atherosclerosis	4.75e-06	0.000236	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—LEP—atherosclerosis	4.75e-06	0.000236	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CAV1—atherosclerosis	4.71e-06	0.000234	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—APOA1—atherosclerosis	4.7e-06	0.000233	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—HMOX1—atherosclerosis	4.67e-06	0.000232	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—APOB—atherosclerosis	4.59e-06	0.000228	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—ESR1—atherosclerosis	4.54e-06	0.000225	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—F2—atherosclerosis	4.48e-06	0.000222	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—APOB—atherosclerosis	4.48e-06	0.000222	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GSTM1—atherosclerosis	4.46e-06	0.000221	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—HMOX1—atherosclerosis	4.4e-06	0.000219	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	4.4e-06	0.000218	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—LPL—atherosclerosis	4.38e-06	0.000217	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—HMOX1—atherosclerosis	4.36e-06	0.000217	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GSTM1—atherosclerosis	4.35e-06	0.000216	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ABCA1—atherosclerosis	4.35e-06	0.000216	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PIK3CG—atherosclerosis	4.29e-06	0.000213	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—LPL—atherosclerosis	4.27e-06	0.000212	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GPX1—atherosclerosis	4.27e-06	0.000212	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—APOB—atherosclerosis	4.22e-06	0.000209	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—APOB—atherosclerosis	4.18e-06	0.000207	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GPX1—atherosclerosis	4.17e-06	0.000207	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CD36—atherosclerosis	4.16e-06	0.000206	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—MAPK3—atherosclerosis	4.11e-06	0.000204	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GSTM1—atherosclerosis	4.1e-06	0.000204	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GSTM1—atherosclerosis	4.07e-06	0.000202	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CD36—atherosclerosis	4.06e-06	0.000202	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—INS—atherosclerosis	4.06e-06	0.000201	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—LPL—atherosclerosis	4.03e-06	0.0002	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CCL2—atherosclerosis	3.99e-06	0.000198	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—LPL—atherosclerosis	3.99e-06	0.000198	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—MTHFR—atherosclerosis	3.94e-06	0.000196	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GPX1—atherosclerosis	3.93e-06	0.000195	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IGF1—atherosclerosis	3.93e-06	0.000195	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GPX1—atherosclerosis	3.89e-06	0.000193	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PPARA—atherosclerosis	3.87e-06	0.000192	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—MTHFR—atherosclerosis	3.85e-06	0.000191	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CD36—atherosclerosis	3.83e-06	0.00019	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CD36—atherosclerosis	3.79e-06	0.000188	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PPARA—atherosclerosis	3.77e-06	0.000187	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—AGT—atherosclerosis	3.75e-06	0.000186	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—HMOX1—atherosclerosis	3.73e-06	0.000185	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—SERPINE1—atherosclerosis	3.73e-06	0.000185	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—APOE—atherosclerosis	3.67e-06	0.000182	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—AGT—atherosclerosis	3.66e-06	0.000181	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CAV1—atherosclerosis	3.64e-06	0.00018	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—APOA1—atherosclerosis	3.63e-06	0.00018	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—MTHFR—atherosclerosis	3.63e-06	0.00018	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—MTHFR—atherosclerosis	3.59e-06	0.000178	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—APOE—atherosclerosis	3.58e-06	0.000178	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—APOB—atherosclerosis	3.57e-06	0.000177	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—NOS3—atherosclerosis	3.56e-06	0.000177	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PPARA—atherosclerosis	3.56e-06	0.000177	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CAV1—atherosclerosis	3.55e-06	0.000176	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—APOA1—atherosclerosis	3.54e-06	0.000176	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PPARA—atherosclerosis	3.53e-06	0.000175	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GSTM1—atherosclerosis	3.48e-06	0.000172	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—AGT—atherosclerosis	3.44e-06	0.000171	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—AGT—atherosclerosis	3.42e-06	0.000169	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—LPL—atherosclerosis	3.41e-06	0.000169	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—APOE—atherosclerosis	3.38e-06	0.000168	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—APOE—atherosclerosis	3.35e-06	0.000166	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CAV1—atherosclerosis	3.34e-06	0.000166	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—APOA1—atherosclerosis	3.34e-06	0.000166	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GPX1—atherosclerosis	3.33e-06	0.000165	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CAV1—atherosclerosis	3.32e-06	0.000165	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PIK3CG—atherosclerosis	3.31e-06	0.000164	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—APOA1—atherosclerosis	3.31e-06	0.000164	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CD36—atherosclerosis	3.24e-06	0.000161	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PIK3CG—atherosclerosis	3.23e-06	0.00016	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PPARG—atherosclerosis	3.2e-06	0.000159	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CXCL8—atherosclerosis	3.16e-06	0.000157	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—INS—atherosclerosis	3.14e-06	0.000156	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PPARG—atherosclerosis	3.12e-06	0.000155	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—MTHFR—atherosclerosis	3.07e-06	0.000152	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—INS—atherosclerosis	3.06e-06	0.000152	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—AKT1—atherosclerosis	3.05e-06	0.000151	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	3.05e-06	0.000151	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PIK3CG—atherosclerosis	3.02e-06	0.00015	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PPARA—atherosclerosis	3.01e-06	0.00015	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—IL6—atherosclerosis	3e-06	0.000149	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PPARG—atherosclerosis	2.94e-06	0.000146	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—AGT—atherosclerosis	2.92e-06	0.000145	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PPARG—atherosclerosis	2.91e-06	0.000145	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—INS—atherosclerosis	2.88e-06	0.000143	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—ALB—atherosclerosis	2.87e-06	0.000143	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—APOE—atherosclerosis	2.86e-06	0.000142	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—INS—atherosclerosis	2.86e-06	0.000142	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MMP9—atherosclerosis	2.86e-06	0.000142	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CAV1—atherosclerosis	2.83e-06	0.000141	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—APOA1—atherosclerosis	2.83e-06	0.00014	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—NFKB1—atherosclerosis	2.83e-06	0.00014	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—ALB—atherosclerosis	2.81e-06	0.000139	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MAPK8—atherosclerosis	2.78e-06	0.000138	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—AKT1—atherosclerosis	2.77e-06	0.000137	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—NOS3—atherosclerosis	2.75e-06	0.000136	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—NOS3—atherosclerosis	2.68e-06	0.000133	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ALB—atherosclerosis	2.64e-06	0.000131	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ALB—atherosclerosis	2.62e-06	0.00013	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PIK3CG—atherosclerosis	2.58e-06	0.000128	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—VEGFA—atherosclerosis	2.56e-06	0.000127	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—STAT3—atherosclerosis	2.54e-06	0.000126	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—NOS3—atherosclerosis	2.53e-06	0.000126	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PTGS2—atherosclerosis	2.51e-06	0.000125	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—NOS3—atherosclerosis	2.51e-06	0.000124	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PPARG—atherosclerosis	2.49e-06	0.000124	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PTGS2—atherosclerosis	2.45e-06	0.000122	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—INS—atherosclerosis	2.44e-06	0.000121	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MAPK3—atherosclerosis	2.43e-06	0.00012	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—TGFB1—atherosclerosis	2.35e-06	0.000117	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PTGS2—atherosclerosis	2.31e-06	0.000115	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PTGS2—atherosclerosis	2.29e-06	0.000114	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ALB—atherosclerosis	2.24e-06	0.000111	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—NOS3—atherosclerosis	2.14e-06	0.000106	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PTGS2—atherosclerosis	1.96e-06	9.72e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IL6—atherosclerosis	1.77e-06	8.8e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—AKT1—atherosclerosis	1.64e-06	8.12e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—AKT1—atherosclerosis	1.26e-06	6.27e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—AKT1—atherosclerosis	1.23e-06	6.12e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—AKT1—atherosclerosis	1.16e-06	5.77e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—AKT1—atherosclerosis	1.15e-06	5.72e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—AKT1—atherosclerosis	9.85e-07	4.89e-05	CbGpPWpGaD
